Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial

Crit Care. 2022 Jan 4;26(1):9. doi: 10.1186/s13054-021-03873-2.

Abstract

ClinicalTrials.gov identifier (NCT number): NCT03852537 , Registered February 25, 2019.

Keywords: C-reactive protein; Coronavirus disease 2019; Corticosteroids.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • COVID-19 Drug Treatment*
  • Humans
  • Pilot Projects
  • Steroids* / administration & dosage
  • Treatment Outcome

Substances

  • Biomarkers
  • Steroids

Associated data

  • ClinicalTrials.gov/NCT03852537